Home › NDC Lookup › RxCUI directory › RxCUI 1148141

3 ML icatibant 10 MG/ML Prefilled Syringe — RxCUI 1148141

RxNorm drug concept · Semantic clinical drug
RxCUI 1148141 Semantic clinical drug · SCD ● Current RxNorm concept 9 FDA products 19 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1148141
Official name3 ML icatibant 10 MG/ML Prefilled Syringe
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asicatibant (as icatibant acetate) 30 MG per 3 ML Prefilled Syringe; icatibant 30 MG in 3 ML Prefilled Syringe
FDA products mapped9
Package NDCs mapped19
Reported Medicaid activity (SDUD)602 prescriptions · 11 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

🕸️ Concept Web — How 3 ML icatibant 10 MG/ML Prefilled Syringe Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept 3 ML icatibant 10 MG/ML Prefilled Syringe RxCUI 1148141

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Icatibant 1148138
  2. Brand names 2

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Firazyr 1148142
    • Sajazir 2569476
  3. Dose forms 8

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Icatibant Prefilled Syringe 1148140
    • Icatibant Injectable Product 1160663
    • Icatibant Prefilled Syringe [Firazyr] 1148144
    • Icatibant Prefilled Syringe [Sajazir] 2569479
    • Firazyr Injectable Product 1168997
    • Sajazir Injectable Product 2569478
    • Prefilled Syringe 721656
    • Injectable Product 1151126
  4. Clinical & branded drugs 5

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 16 of 16 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Icatibant 10 MG/ML SCDC · 1148139
  • Icatibant Prefilled Syringe SCDF · 1148140
  • Icatibant Injectable Product SCDG · 1160663

Brand-Name Concepts

📦 FDA Products & Package NDCs

9 products · 19 package NDCs
19 package NDCs map to RxCUI 1148141 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00093-3066-34 1 SYRINGE in 1 CARTON (0093-3066-34) / 3 mL in 1 SYRINGE Icatibant Teva Pharmaceuticals USA, Inc. 2019-07-15
00093-3066-93 3 CARTON in 1 BOX (0093-3066-93) / 1 SYRINGE in 1 CARTON (0... Icatibant Teva Pharmaceuticals USA, Inc. 2019-07-15
24201-0207-01 1 SYRINGE, GLASS in 1 CARTON (24201-207-01) / 3 mL in 1 SYR... Icatibant Hikma Pharmaceuticals USA Inc. 2020-03-09
24201-0207-03 3 CARTON in 1 CARTON (24201-207-03) / 1 SYRINGE, GLASS in 1... Icatibant Hikma Pharmaceuticals USA Inc. 2020-03-09
46708-0654-03 1 SYRINGE, GLASS in 1 CARTON (46708-654-03) / 3 mL in 1 SYR... Icatibant Alembic Pharmaceuticals Limited 2024-06-14
46708-0654-09 3 SYRINGE, GLASS in 1 CARTON (46708-654-09) / 3 mL in 1 SYR... Icatibant Alembic Pharmaceuticals Limited 2024-06-14
54092-0702-01 1 SYRINGE, GLASS in 1 CARTON (54092-702-01) / 3 mL in 1 SYR... Firazyr Takeda Pharmaceuticals America, Inc. 2011-08-25
54092-0702-02 1 SYRINGE, GLASS in 1 CARTON (54092-702-02) / 3 mL in 1 SYR... Firazyr Takeda Pharmaceuticals America, Inc. 2011-08-25
54092-0702-03 3 SYRINGE, GLASS in 1 CARTON (54092-702-03) / 3 mL in 1 SYR... Firazyr Takeda Pharmaceuticals America, Inc. 2011-08-25
55150-0351-01 1 SYRINGE, GLASS in 1 CARTON (55150-351-01) / 3 mL in 1 SYR... Icatibant Eugia US LLC 2023-08-14
55150-0351-03 3 CARTON in 1 CARTON (55150-351-03) / 1 SYRINGE, GLASS in 1... Icatibant Eugia US LLC 2023-08-14
62332-0654-03 1 SYRINGE, GLASS in 1 CARTON (62332-654-03) / 3 mL in 1 SYR... Icatibant Alembic Pharmaceuticals Inc. 2024-06-14
62332-0654-09 3 SYRINGE, GLASS in 1 CARTON (62332-654-09) / 3 mL in 1 SYR... Icatibant Alembic Pharmaceuticals Inc. 2024-06-14
63323-0574-86 1 SYRINGE in 1 CARTON (63323-574-86) / 3 mL in 1 SYRINGE (6... Icatibant Fresenius Kabi USA, LLC 2020-11-15
63323-0574-93 3 CARTON in 1 BOX (63323-574-93) / 1 SYRINGE in 1 CARTON /... Icatibant Fresenius Kabi USA, LLC 2020-11-15
69097-0664-34 1 SYRINGE, GLASS in 1 CARTON (69097-664-34) / 3 mL in 1 SYR... ICATIBANT Cipla USA Inc. 2020-07-13
69097-0664-68 3 SYRINGE, GLASS in 1 CARTON (69097-664-68) / 3 mL in 1 SYR... ICATIBANT Cipla USA Inc. 2020-07-13
70709-0013-01 1 SYRINGE, GLASS in 1 CARTON (70709-013-01) / 3 mL in 1 SYR... SAJAZIR Cycle Pharmaceuticals Ltd-Uk 2021-06-03
70709-0013-03 3 SYRINGE, GLASS in 1 CARTON (70709-013-03) / 3 mL in 1 SYR... SAJAZIR Cycle Pharmaceuticals Ltd-Uk 2021-06-03
Observed labelers: Takeda Pharmaceuticals America, Inc. (3) · Alembic Pharmaceuticals Inc. (2) · Alembic Pharmaceuticals Limited (2) · Cipla USA Inc. (2) · Cycle Pharmaceuticals Ltd-Uk (2) · Eugia US LLC (2) · +3 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.